|
Sign In to gain access to subscriptions and/or personal tools.
|
Angiotensin II binding and extracellular matrix remodelling in a rat model of myocardial infarction
Marwan E El-Sabban
Department of Human Morphology, Faculty of Medicine, American University of Beirut
Khaled A Hassan
Department of Physiology, American University of Beirut
Adel E Birbari
Department of Physiology, American University of Beirut
Khalil M Bitar
Department of Physics, Faculty of Arts and Sciences, American University of Beirut, Beirut, Lebanon
Anwar B Bikhazi
Department of Physiology, American University of Beirut, ab04@ aub.lb.edu
Clinical evidence points to a role for angiotensin II (Ang II) in the post-infarction remodelling of cardiac hypertrophy. The present study was designed to investigate the remodelling process in an animal model of myocardial infarction (MI) using the following criteria: 1) histological studies to examine the re-vascularisation process and collagen deposition in different regions of the myocardium; 2) histological evidence to investigate the cell type distribution using cell-specific markers; 3) histological and Western blot analysis to localise Ang II receptor subtypes (AT1-receptor and AT2-receptor) and to study their regulation; 4) kinetics of the binding of Ang II to its receptors in a heart perfusion model; and 5) to assess the effect of the Ang II antagonist (losartan) on these parameters.
MI was induced by ligation of the left anterior descending coronary artery of Sprague-Dawley rats. Four different animal groups were established: 1) sham-operated, non-treated; 2) sham-operated, treated with losartan; 3) myocardial infarct, non-treated; and
4) myocardial infarct, treated with losartan. In infarcted rat hearts, fibroblasts and collagen types I and III increased in the remnant viable region of the left ventricle compared with sham-operated rats. One month of losartan treatment in myocardial infarcted rats revealed insignificant changes in fibroblasts and collagen types I and III compared with sham controls. Also, myocardial infarction increased AT1-receptor protein levels compared with sham-operated controls, as judged by Western blotting. In losartan-treated myocardial infarct animals, no changes were detected at the level of AT1-receptor expression compared with non-treated myocardial infarct rats. Binding studies of Ang II on endothelial cell lining and directly on myocytes in sham-operated and infarcted perfused rat hearts revealed that, in myocardial infarcted-animals, Ang II binding affinity increased both in the endothelium and in myofibres. This may be considered a major putative effect of the peptide in potentiating the pharmacodynamics of hypertrophy. In losartan-treated myocardial infarcted-animals, a marked increase in the binding affinities of Ang II for the AT2-receptor subtype was observed. Hence, potential cardioprotective effects of the AT 1-receptor antagonist are proposed.
Key Words: angiotensin myocardial infarction remodelling losartan
References
- Nakamaru M., Inagami T., Ogihara T., Kumahara Y. Effect of captopril on angiotensin II release from vascular tissues in rats. Clin Exp Hypertens 1987; 9:477-80.[Web of Science]
- Mizuno K., Tani M., Niimura S. et al. Direct evidence for local generation and release of angiotensin II in human vascular tissue. Biochem Biophys Res Commun 1989; 165:457-63.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Unger T., Gohlke P. Tissue renin-angiotensin systems in the heart and vasculature: possible involvement in the cardiovascular actions of converting enzyme inhibitors. Am J Cardiol 1990; 65:31-101.
- Rogg H., Schmid A., de Gasparo M. Identification and characterization of angiotensin II receptor subtypes in rabbit ventricular myocardium. Biochem Biophys Res Commun 1990;173: 416-22.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Suzuki J., Matsubara H., Urakami M., Inada M. Rat angiotensin II (Type1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. Circ Res 1993; 73: 439-47.[Abstract/Free Full Text]
- Lees KR, MacFadyen RJ, Doig JK, Reid JL Role of angiotensin in the extravascular system. J Human Hyper 1993; 7: S7-S12.
- Sasamura H., Dzau VJ, Pratt RE Desensitization of angiotensin receptor function. Kidney Int 1994; 46:1499-501.[Web of Science][Medline]
[Order article via Infotrieve]
- Stoll M., Muscha Steckelings U., Paul M., Bottari SP, Metzger R,Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995; 95: 651-7.[Web of Science][Medline]
[Order article via Infotrieve]
- Lijnen P., Petrov V. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes. J Mol Cell Cardiol 1999; 31:949-70.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Sadoshima J., Xu Y., Slayter HS, Izumo S. Autocrine release of angiotensin II mediates stretch induced hypertrophy of cardiac myocytes in vitro. Cell 1993; 75:977-84.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Nio Y., Matsubara Y., Murasawa S., Kanasaki M., Inada M. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest 1995; 95:46-54.[Web of Science][Medline]
[Order article via Infotrieve]
- Glagov S. Mechanical determinants of intimal adaptive reactions and restenosis. Circulation 1994; 89:2888-91.[Free Full Text]
- Timmermans PB, Wong PC, Chiu AT, Herblin WF Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol-Rev 1993; 45:205-51.[Web of Science][Medline]
[Order article via Infotrieve]
- Morgan HE, Baker KM Cardiac hypertrophy. Mechanical, neural, and endocrine dependence. Circulation 1991; 83:13-25.[Free Full Text]
- Weber KT, Brilla CG Pathological hypertrophy and cardiac interstitium: Fibrosis and renin-angiotensin-aldosterone system. Circulation 1991; 83:1849-65.[Abstract/Free Full Text]
- Bishop JE Regulation of cardiovascular collagen deposition by mechanical forces. Mol Med Tod 1998; 4:69-75.[CrossRef]
- Suzuki J., Matsubara H., Urakami M., Inada M. Rat angiotensin II (Type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. Circ Res 1993; 73:439-47.[Abstract/Free Full Text]
- Hynes RO Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992; 69:11-25.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Lu L., Xu Y., Greyson CR, Ursell PC, Schwartz GG Non-elastic deformation of myocardium in low-flow ischemia and reperfusion: Ultrastructure-function relations. J Mol Cell Cardiol 1999; 3l:1157-69.
- Haddad, RE, Jurjus AR, Ibrahim MZM et al. Binding of 125I-Insulin on capillary endothelial and myocyte cell membranes in normal and streptozotocin-induced diabetic perfused rat hearts. Comp Biochem Physiol 1997; 117A:523-30.
- Janqueira L., Carneiro J., Kelly R. Basic Histology. San Mateo, CA: Appleton and Lange, 1995.
- Liu YH,Yang XP, Sharov VG et al. Effects of angotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure J Clin Invest 1997; 99:1926-35.[Web of Science][Medline]
[Order article via Infotrieve]
- Ullian ME, Linas SL Role of receptor cycling in the regulation of angiotensin II surface receptor number and angiotensin II uptake in rat vascular smooth muscle cells. J Clin Invest 1989; 84:840-6.[Web of Science][Medline]
[Order article via Infotrieve]
- Sandberg K., Ji H., Clark AJL, Shapira H., Catt KJ Cloning and expression of a novel angiotensin II receptor subtype. J Biol Chem 1992; 267:9455-8.[Abstract/Free Full Text]
- Matsubara H., Kanasaki M., Murasawa S., Tsukaguchi Y., Nio Y., Inada M. Differential gene expression and regulation of angiotensin II receptor subtypes in rat cardiac fibroblasts and cardiomyocytes in culture. J Clin Invest 1994; 93:1592-601.[Web of Science][Medline]
[Order article via Infotrieve]
- BikhaziAB, Haddad RE, Nahlé ZA, Bitar KM Angiotensin II delivery and binding at the microvascular endothelium and cardiac myocyte surfaces in perfused rat hearts. J Pharm Sci 1998; 87:1363-7.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Matsubara H., Nio Y., Murasawa S. et al. Regulation of gene transcription of angiotensin II receptor subtypes in the heart. In: Recent advances in cellular and molecular aspects of angiotensin receptors. Ed. Mohan K. Raizada et al., (eds). Plenum Press: New York, 1996: 23-32.
- Takewaki S., Karo-o M., Hiroi Y. et al. Activation of Na+-H+ antiporter (NHE-1) gene expression during growth, hypertrophy and proliferation of the rabbit cardiovascular system.JMol Cell Biol 1995; 27:729-42.
- Juliano RL, Haskill S. Signal transduction from the extracellular matrix. J Cell Biol 1993; 120:577-85.[Free Full Text]
- YamazakiT, Komuro I., Kudoh S. et al. Role of ion channels and exchangers in mechanical stretch-induced cardiomyocyte hypertrophy. Circ Res 1998; 82:430-7.[Abstract/Free Full Text]
- Kijima K., Matsubaro H., Murasawa S. et al. Mechanical stretch induces enhanced expression of angiotensin II receptor subtypes in neonatal rat cardiac myocytes. Circ Res 1996; 79:887-97.[Abstract/Free Full Text]
- Haywood GA, Gullestad L., Katsuya T. et al. AT1 and AT2 angiotensin receptor gene expression in human heart failure. Circulation 1997; 95:1201-6.[Abstract/Free Full Text]
- Booz GW, Baker KM Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy. Hypertension 1996; 28:635-40.[Abstract/Free Full Text]
- Horiuchi M., Akishita M., Dzau VJ Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension 1999; 33:613-21.[Abstract/Free Full Text]
Journal of Renin-Angiotensin-Aldosterone System, Vol. 1, No. 4,
369-378 (2000)
DOI: 10.3317/jraas.2000.069

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|